Valiant Laboratories Ltd (VALIANTLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039033,
    "name": "Valiant Laborato",
    "stock_name": "Valiant Laborato",
    "full_name": "Valiant Laboratories Ltd",
    "name_url": "stocks-analysis/valiant-laborato",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "67.85",
    "chg": -0.1,
    "chgp": "-0.15%",
    "dir": -1,
    "prev_price": "67.95",
    "mcapval": "369.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543998,
    "symbol": "VALIANTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0JWS01017",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "19.6 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/valiant-laborato-10039033-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Valiant Laboratories Ltd Valuation Shifts Signal Heightened Price Risk",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-valuation-shifts-signal-heightened-price-risk-3997935",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ValiantLaborato_valuationdot_3997935.png",
        "date": "2026-05-19 08:02:54",
        "description": "Valiant Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation metrics shift markedly, moving from an already expensive rating to very expensive territory. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock has delivered mixed returns compared to the broader Sensex, prompting investors to reassess its price attractiveness amid challenging fundamentals and peer comparisons."
      },
      {
        "title": "When is the next results date for Valiant Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-valiant-laboratories-ltd-3988233",
        "imagepath": "",
        "date": "2026-05-12 23:17:42",
        "description": "Valiant Laboratories Ltd is scheduled to declare its results on 14 May 2026...."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3975755",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ValiantLaborato_mojoScore_3975755.png",
        "date": "2026-05-05 10:10:34",
        "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Valiant Laboratories Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3969816",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ValiantLaborato_stocks_hitting_lower_circuit_3969816.png",
        "date": "2026-04-30 10:00:20",
        "description": "At Rs 77.57, sellers were still queuing — but there were no buyers willing to take the other side. Valiant Laboratories Ltd locked at its lower circuit of 5.0% on 30 Apr 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3960632",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ValiantLaborato_mojoScore_3960632.png",
        "date": "2026-04-24 10:10:31",
        "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 24 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3944603",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ValiantLaborato_mojoScore_3944603.png",
        "date": "2026-04-13 10:10:32",
        "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3930146",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ValiantLaborato_mojoScore_3930146.png",
        "date": "2026-04-02 10:10:29",
        "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      }
    ],
    "total": 15,
    "sid": "10039033",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/valiant-laboratories-10039033"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "30-May-2026",
      "details": "Please find enclosed",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "22-May-2026",
      "details": "Annual Secretarial Compliance Report for the Financial Year 2025-2026.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011",
      "datetime": "20-May-2026",
      "details": "The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Valiant Organics Ltd",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Laboratories Ltd has announced <strong>1:4</strong> rights issue, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Valiant Laboratories Ltd Valuation Shifts Signal Heightened Price Risk

2026-05-19 08:02:54

Valiant Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation metrics shift markedly, moving from an already expensive rating to very expensive territory. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock has delivered mixed returns compared to the broader Sensex, prompting investors to reassess its price attractiveness amid challenging fundamentals and peer comparisons.

When is the next results date for Valiant Laboratories Ltd?

2026-05-12 23:17:42

Valiant Laboratories Ltd is scheduled to declare its results on 14 May 2026....

Valiant Laboratories Ltd is Rated Strong Sell

2026-05-05 10:10:34

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Valiant Laboratories Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight

2026-04-30 10:00:20

At Rs 77.57, sellers were still queuing — but there were no buyers willing to take the other side. Valiant Laboratories Ltd locked at its lower circuit of 5.0% on 30 Apr 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

Valiant Laboratories Ltd is Rated Strong Sell

2026-04-24 10:10:31

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 24 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Valiant Laboratories Ltd is Rated Strong Sell

2026-04-13 10:10:32

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Valiant Laboratories Ltd is Rated Strong Sell

2026-04-02 10:10:29

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

View All News